- Home
- VTRS vs TKO Comparison
VTRS vs TKO Comparison
Compare VTRS & TKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTRS
- TKO
- Stock Information
- Founded
- VTRS 1961
- TKO 1980
- Country
- VTRS United States
- TKO United States
- Employees
- VTRS N/A
- TKO N/A
- Industry
- VTRS Medicinal Chemicals and Botanical Products
- TKO
- Sector
- VTRS Health Care
- TKO
- Exchange
- VTRS Nasdaq
- TKO Nasdaq
- Market Cap
- VTRS 14.0B
- TKO 11.6B
- IPO Year
- VTRS N/A
- TKO N/A
- Fundamental
- Price
- VTRS $11.30
- TKO $142.12
- Analyst Decision
- VTRS Hold
- TKO Strong Buy
- Analyst Count
- VTRS 3
- TKO 14
- Target Price
- VTRS $13.67
- TKO $140.86
- AVG Volume (30 Days)
- VTRS 10.6M
- TKO 730.2K
- Earning Date
- VTRS 02-26-2025
- TKO 02-27-2025
- Dividend Yield
- VTRS 4.25%
- TKO N/A
- EPS Growth
- VTRS N/A
- TKO N/A
- EPS
- VTRS N/A
- TKO N/A
- Revenue
- VTRS $15,048,500,000.00
- TKO $2,776,140,000.00
- Revenue This Year
- VTRS N/A
- TKO $66.81
- Revenue Next Year
- VTRS N/A
- TKO $13.24
- P/E Ratio
- VTRS N/A
- TKO N/A
- Revenue Growth
- VTRS N/A
- TKO 108.30
- 52 Week Low
- VTRS $9.93
- TKO $76.04
- 52 Week High
- VTRS $13.62
- TKO $149.40
- Technical
- Relative Strength Index (RSI)
- VTRS 28.18
- TKO 52.83
- Support Level
- VTRS $11.13
- TKO $140.94
- Resistance Level
- VTRS $12.02
- TKO $145.00
- Average True Range (ATR)
- VTRS 0.32
- TKO 3.81
- MACD
- VTRS -0.09
- TKO -0.55
- Stochastic Oscillator
- VTRS 10.97
- TKO 46.43
About VTRS Viatris Inc.
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
About TKO TKO Group Holdings Inc.
TKO Group Holdings Inc is a premium sports and entertainment company that comprises UFC, the world's mixed martial arts organization, and WWE, an integrated media organization and the recognized leader in sports entertainment.